carmen li

Jul 15, 2013

Ethical grounding likely to help minimise GSK fallout in China

BEIJING – PR industry observers suggest that recent confessions by GlaxoSmithKline (GSK) executives to involvement in bribery and tax offences in China are unlikely to prove a long-term setback for the company.